HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The use of dioxadet in chemoembolization of the hepatic artery in primary and metastatic cancer of the liver].

Abstract
An evaluation of the treatment of 42 patients with extended primary hepatic tumors and multiple intrahepatic metastases of colorectal carcinoma established the effectiveness of a newly-developed fat-soluble cytostatic drug--dioxadet, used for chemoembolization particularly, when foci fed from small arterial vessels were located along the periphery.
AuthorsA E Borisov, M L Gershanovich, V P Zemlianoĭ, S L Nepomniashchaia, A N Stukov, V A Filov
JournalVoprosy onkologii (Vopr Onkol) Vol. 44 Issue 6 Pg. 714-7 ( 1998) ISSN: 0507-3758 [Print] Russia (Federation)
Vernacular TitleIspol'zovanie dioksadéta dlia khimioémbolizatsii pechenochnoĭ arterii pri pervichnom i metastaticheskom rake pecheni.
PMID10087972 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Triazines
  • dioxadet
Topics
  • Adult
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Chemoembolization, Therapeutic (methods)
  • Female
  • Hepatic Artery
  • Humans
  • Liver Neoplasms (pathology, therapy)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome
  • Triazines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: